Pharmacogenomics of fluorouracil -based chemotherapy toxicity.

Pharmacogenomics of fluorouracil -based chemotherapy toxicity.

Item
http://www.wikidata.org/entity/Q38387640
Genetic factors affecting drug disposition in Asian cancer patients.Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery.Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.Fluoropyrimidine and platinum toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.Successful use of uridine triacetate (Vistogard) three weeks after capecitabine in a patient with homozygous dihydropyrimidine dehydrogenase mutation: A case report and review of the literature.Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy.Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac.Renal inhibition of miR-181a ameliorates 5-fluorouracil-induced mesangial cell apoptosis and nephrotoxicity.
P2860

Pharmacogenomics of fluorouracil -based chemotherapy toxicity.

Item
http://www.wikidata.org/entity/Q38387640
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacogenomics of fluorouracil -based chemotherapy toxicity.
@en
type
label
Pharmacogenomics of fluorouracil -based chemotherapy toxicity.
@en
prefLabel
Pharmacogenomics of fluorouracil -based chemotherapy toxicity.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Pharmacogenomics of fluorouracil -based chemotherapy toxicity.
@en
P2093
P2860
P304
P31
P356
10.1517/17425255.2015.1027684
P407
P433
P478
P50
P577
P5875
P698
P921